B
TMO icon

Bayban’s Thermo Fisher Scientific TMO Stock Holding History

Bayban’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.02K Sell
18
-143
-89% -$68.6K 0.01% 413
2026
Q1 		$79.1K Hold
161
– – 0.07% 186
2025
Q4 		$93.3K Buy
+161
New +$91K 0.08% 171

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Bayban's TMO Position: Q2 2026 in Review

Bayban reduced its Thermo Fisher Scientific (TMO) stake by 89% in Q2 2026, selling an estimated $68.6K and leaving 18 shares worth $9.02K. The position accounts for 0.01% of the portfolio, ranked #413.

Bayban first reported a position in TMO in Q4 2025 and has held it in 3 quarters since. The position peaked at $93.3K in Q4 2025. 2,508 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Bayban held 18 shares of Thermo Fisher Scientific worth $9.02K as of Q2 2026.
  • Bayban sold 143 Thermo Fisher Scientific shares in Q2 2026, an estimated $68.6K.
  • Thermo Fisher Scientific made up 0.01% of Bayban's portfolio in Q2 2026, its #413 holding.
  • Bayban first reported a position in Thermo Fisher Scientific in Q4 2025 and has held it in 3 quarters since.
  • Bayban's Thermo Fisher Scientific position peaked at $93.3K in Q4 2025.
  • 2,508 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Bayban's 13F filing for Q2 2026, filed 30 Jul 2026.